Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs – The New York Times

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs The New York Times
Novo Nordisk ousts CEO after falling behind in weight loss market Reuters
Hims Stock Rockets On Novo Nordisk Partnership After FDA Weight-Loss Drug Ruling Crashes Shares Investor’s Business Daily

Brought to you by Google News. Read the rest of the article here.